Co-Authors
This is a "connection" page, showing publications co-authored by DONALD BERRY and XUELIN HUANG.
Connection Strength
0.961
-
Using short-term response information to facilitate adaptive randomization for survival clinical trials. Stat Med. 2009 May 30; 28(12):1680-9.
Score: 0.344
-
A parallel phase I/II clinical trial design for combination therapies. Biometrics. 2007 Jun; 63(2):429-36.
Score: 0.300
-
Building and validating a prognostic index for biomarker studies. Cancer Biomark. 2006; 2(3-4):97-101.
Score: 0.272
-
Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes. Leuk Lymphoma. 2010 Jan; 51(1):73-8.
Score: 0.022
-
DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol. 2010 Feb 01; 28(4):605-13.
Score: 0.022